MRKR NASDAQ
Marker Therapeutics, Inc.
1W: -8.7%
1M: -16.0%
3M: -29.1%
YTD: -31.8%
1Y: +15.6%
3Y: -77.8%
5Y: -94.1%
$1.05
+0.00 (+0.00%)
Weekly Expected Move ±7.4%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$1M
Revenue
-77.1% YoY
$-9M
Net Income
+40.4% YoY
$-10M
Free Cash Flow
+10.4% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-76.9%
ROA-59.3%
ROIC-1014.3%
Valuation
P/E-2.2
P/B1.7
EV/EBITDA-2.0
Leverage
Debt/Equity0.00
Current Ratio6.03
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z-38.40
Beneish M0.00